Article Information
History
- May 31, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Samuel Okurut1,2,*,
- David R. Boulware3,
- Yukari C. Manabe1,4,
- Lillian Tugume1,
- Caleb P. Skipper3,
- Kenneth Ssebambulidde1,
- Joshua Rhein3,
- Abdu K. Musubire1,
- Andrew Akampurira1,2,
- Elizabeth Okafor3,
- Joseph O. Olobo5,
- Edward N. Janoff6,7,
- David B. Meya1,3,8,
- ASTRO Trial Team
- 1Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda
- 2Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
- 3Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
- 4Division of Infectious Diseases, Department of Medicine, John Hopkins University School of Medicine, Baltimore, Maryland, MD, USA
- 5Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
- 6Mucosal and Vaccine Research Program Colorado, Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, CO. USA
- 7Rocky Mountain Regional Veterans Affairs Medical Center, Aurora CO, USA
- 8Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
- ↵*Correspondence to
: Samuel Okurut, Infectious Diseases Institute, College of Health Sciences, Makerere University, Box 22418, Kampala, Uganda. Email: okuruts{at}gmail.com, Mobile: +256 782, 003931
Posted May 31, 2024.
Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal Meningitis
